Aurobindo to widen US portfolio, enter new markets in Europe
Lower generics penetration in Italy, Spain, Portugal and France offers future growth potential in next three to four years as share of generics improves, it added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | France Health | Italy Health | Pharmaceuticals | Portugal Health | Spain Health